Does RIVASTIGMINE Cause Application site discolouration? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Application site discolouration have been filed in association with RIVASTIGMINE (Exelon). This represents 0.4% of all adverse event reports for RIVASTIGMINE.
37
Reports of Application site discolouration with RIVASTIGMINE
0.4%
of all RIVASTIGMINE reports
1
Deaths
5
Hospitalizations
How Dangerous Is Application site discolouration From RIVASTIGMINE?
Of the 37 reports, 1 (2.7%) resulted in death, 5 (13.5%) required hospitalization.
Is Application site discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIVASTIGMINE. However, 37 reports have been filed with the FAERS database.
What Other Side Effects Does RIVASTIGMINE Cause?
Death (1,229)
Fall (587)
Malaise (514)
Drug ineffective (510)
Product adhesion issue (478)
Vomiting (432)
Dementia alzheimer's type (428)
Memory impairment (385)
Nausea (383)
Pneumonia (378)
What Other Drugs Cause Application site discolouration?
SUMATRIPTAN (684)
BUPRENORPHINE (208)
INGENOL MEBUTATE (115)
MECHLORETHAMINE (101)
ESTRADIOL (89)
NICOTINE (87)
MINOXIDIL (76)
SALICYLIC ACID (76)
BECAPLERMIN (74)
DICLOFENAC (67)
Which RIVASTIGMINE Alternatives Have Lower Application site discolouration Risk?
RIVASTIGMINE vs RIVOTRIL
RIVASTIGMINE vs RIZATRIPTAN
RIVASTIGMINE vs ROACTEMRA
RIVASTIGMINE vs ROCURONIUM
RIVASTIGMINE vs ROFECOXIB